Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.

[1]  L. Peyrin-Biroulet,et al.  Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics , 2012, Inflammatory bowel diseases.

[2]  U. Mansmann,et al.  Infliximab Does Not Affect Postoperative Complication Rates in Crohn's Patients Undergoing Abdominal Surgery , 2012, Inflammatory bowel diseases.

[3]  F. Bendtsen,et al.  Infliximab and complications after colectomy in patients with ulcerative colitis. , 2012, Journal of Crohn's & colitis.

[4]  S. Wexner,et al.  Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates? , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[5]  G. Kaplan,et al.  Postoperative complications and mortality following colectomy for ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  L. Peyrin-Biroulet,et al.  Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review. , 2011, Current drug targets.

[7]  E. Dozois,et al.  Perioperative complications in inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[8]  L. Peyrin-Biroulet,et al.  Surgery for adult Crohn's disease: what is the actual risk? , 2011, Gut.

[9]  L. Guidi,et al.  Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience , 2011, International Journal of Colorectal Disease.

[10]  J. Nogueras,et al.  Short‐term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[11]  R. Cross,et al.  Preoperative Use of Anti-TNF Therapy in Crohn's Disease Patients is Associated With Increased Infectious and Surgical Complications , 2011 .

[12]  J. Becker,et al.  Preoperative Infliximab is not Associated with an Increased Risk of Short-Term Postoperative Complications After Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis , 2011, Journal of Gastrointestinal Surgery.

[13]  L. Peyrin-Biroulet,et al.  Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.

[14]  W. Sandborn,et al.  Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease , 2010, Journal of Gastrointestinal Surgery.

[15]  M. Regueiro,et al.  Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center , 2010, Inflammatory bowel diseases.

[16]  J. Potter,et al.  763 Outcome of Acute Severe Ulcerative Colitis: Data From the UK National IBD Audit , 2010 .

[17]  J. Church,et al.  Factors Associated With Septic Complications After Restorative Proctocolectomy , 2010, Annals of surgery.

[18]  R. Hodin,et al.  Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery , 2010, International Journal of Colorectal Disease.

[19]  Zhiping Yang,et al.  Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis , 2010, Alimentary pharmacology & therapeutics.

[20]  M. Barthet,et al.  Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch–anal anastomosis: a case-matched study , 2010, Surgical Endoscopy.

[21]  P. Rutgeerts,et al.  Corticosteroids but not infliximab increase short‐term postoperative infectious complications in patients with ulcerative colitis , 2009, Inflammatory bowel diseases.

[22]  J. Efron,et al.  Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients , 2009, World Journal of Surgery.

[23]  R. Cima,et al.  Does infliximab increase complications after surgery for inflammatory bowel disease? , 2009, F1000 medicine reports.

[24]  A. Means,et al.  Central control of feeding , 2009, F1000 biology reports.

[25]  S. Saxena,et al.  Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery , 2008, The American Journal of Gastroenterology.

[26]  J. Korzenik,et al.  Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications , 2008, Journal of Gastrointestinal Surgery.

[27]  J. Church,et al.  Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients , 2008, Journal of Gastrointestinal Surgery.

[28]  G. Paintaud,et al.  Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients , 2008, Therapeutic drug monitoring.

[29]  F. Remzi,et al.  Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy , 2008, Diseases of the colon and rectum.

[30]  S. Targan,et al.  Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis? , 2007, Diseases of the colon and rectum.

[31]  W. Harmsen,et al.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. , 2007, Journal of the American College of Surgeons.

[32]  E. Vicaut,et al.  Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.

[33]  V. Bykerk,et al.  Consensus Statement , 2004, Pediatric Clinical Practice Guidelines & Policies.

[34]  W. Harmsen,et al.  Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy , 2004, American Journal of Gastroenterology.

[35]  P. Rutgeerts,et al.  The risk of post‐operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study , 2004, Alimentary pharmacology & therapeutics.

[36]  D. Binion,et al.  Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. , 2003, Surgery.

[37]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[38]  J. Lewis,et al.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.

[39]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[40]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[41]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. , 2000, JAMA.

[42]  Bias in meta›analysis detected by a simple, graphical test , 1998 .